Answers are grounded in this paper and cite their sources.
Review synthesizes evidence linking PFOS exposure to mitochondrial dysfunction and its consequences.
Perfluorooctane sulfonate (PFOS), a persistent member of the per-and polyfluoroalkyl substances family, is widely detected in human tissues and is increasingly linked to metabolic, inflammatory, and reproductive disorders.Unlike conventional environmental stressors that passively disrupt ion gradients or act as indirect oxidative stressors, PFOS exhibits a distinct structural scaffolding signature, actively reconfiguring inter-organelle communication networks through cytoskeletal-dependent physical tethering of ion transport machineries.Emerging evidence suggests that PFOS acts as a disruptor of mitochondrial ion homeostasis, reshaping inter-organelle communication networks that regulate calcium and iron trafficking.PFOS exposure perturbs mitochondrial calcium and iron fluxes, enhancing calcium transfer at mitochondriaassociated membranes and promoting lysosome-and endoplasmic reticulum-derived iron delivery to mitochondria via specific interorganelle couplings, including the TRPML1-VDAC3 and ZIP7-VDAC3 axes.Sustained mitochondrial calcium accumulation lowers bioenergetic resilience through increased reactive oxygen species production and permeability transition, while preferential iron loading expands the pool of redox-active Fe 2+ , amplifying lipid peroxidation and ferroptotic execution.PFOS appears to spatially reprogram ion trafficking networks, converting mitochondria from adaptive metabolic regulators into amplifiers of oxidative and inflammatory injury.This review synthesizes recent mechanistic findings and proposes an ion-centered framework linking PFOS exposure to mitochondrial dysfunction, ferroptosis, and downstream pathophysiology.
No takes yet. Share an insight, caveat, or question.
Ahn et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: